Production, characterization, and antigen specificity of recombinant 62‐71‐3, a candidate monoclonal antibody for rabies prophylaxis in humans
Open Access
- 31 January 2013
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 27 (5), 2055-2065
- https://doi.org/10.1096/fj.12-219964
Abstract
Rabies kills many people throughout the developing world every year. The murine monoclonal antibody (mAb) 62-71-3 was recently identified for its potential application in rabies postexposure prophylaxis (PEP). The purpose here was to establish a plant-based production system for a chimeric mouse-human version of mAb 62-71-3, to characterize the recombinant antibody and investigate at a molecular level its interaction with rabies virus glycoprotein. Chimeric 62-71-3 was successfully expressed in Nicotiana benthamiana. Glycosylation was analyzed by mass spectroscopy; functionality was confirmed by antigen ELISA, as well as rabies and pseudotype virus neutralization. Epitope characterization was performed using pseudotype virus expressing mutagenized rabies glycoproteins. Purified mAb demonstrated potent viral neutralization at 500 IU/mg. A critical role for antigenic site I of the glycoprotein, as well as for two specific amino acid residues (K226 and G229) within site I, was identified with regard to mAb 62-71-3 neutralization. Pseudotype viruses expressing glycoprotein from lyssaviruses known not to be neutralized by this antibody were the controls. The results provide the molecular rationale for developing 62-71-3 mAb for rabies PEP; they also establish the basis for developing an inexpensive plant-based antibody product to benefit low-income families in developing countries.—Both, L., van Dolleweerd, C., Wright, E., Banyard, A. C., Bulmer-Thomas, B., Selden, D., Altmann, F., Fooks, A. R., Ma, J. K.-C. Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans. FASEB J. 27, 2055–2065 (2013). www.fasebj.orgKeywords
This publication has 67 references indexed in Scilit:
- Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral MoleculesPLOS ONE, 2011
- Quantifying Antigenic Relationships among the LyssavirusesJournal of Virology, 2010
- Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in HumansPLoS Neglected Tropical Diseases, 2009
- pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plantsPlant Biotechnology Journal, 2009
- Furious Rabies after an Atypical ExposurePLoS Medicine, 2009
- Rabies Exposures, Post-Exposure Prophylaxis and Deaths in a Region of Endemic Canine RabiesPLoS Neglected Tropical Diseases, 2008
- Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparisonJournal of General Virology, 2008
- Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: Safety and immunogenicity in a phase I clinical studyProceedings of the National Academy of Sciences of the United States of America, 2008
- Rabies Encephalitis in Malaria-Endemic Area, Malawi, AfricaEmerging Infectious Diseases, 2007
- Production of antibodies in transgenic plantsNature, 1989